 Shu-Yi Liao
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoidosis | 4 | 2025 | 159 | 2.380 |
Why?
| | Gene-Environment Interaction | 1 | 2023 | 194 | 0.750 |
Why?
| | Granuloma | 1 | 2021 | 91 | 0.700 |
Why?
| | Genetic Predisposition to Disease | 3 | 2024 | 2417 | 0.680 |
Why?
| | Adenomyosis | 2 | 2017 | 4 | 0.670 |
Why?
| | Endometrium | 2 | 2017 | 58 | 0.660 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1434 | 0.640 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 249 | 0.640 |
Why?
| | beta 2-Microglobulin | 1 | 2018 | 50 | 0.610 |
Why?
| | Asthma | 2 | 2022 | 2290 | 0.570 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 176 | 0.570 |
Why?
| | Transcriptome | 1 | 2024 | 971 | 0.550 |
Why?
| | HLA Antigens | 1 | 2018 | 237 | 0.540 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 202 | 0.540 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 551 | 0.530 |
Why?
| | Carcinoma, Renal Cell | 1 | 2018 | 214 | 0.500 |
Why?
| | Infertility, Female | 1 | 2017 | 108 | 0.500 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2025 | 83 | 0.420 |
Why?
| | Macrophages | 1 | 2021 | 1541 | 0.410 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 1042 | 0.390 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 126 | 0.370 |
Why?
| | Antibody Formation | 2 | 2022 | 298 | 0.340 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2491 | 0.310 |
Why?
| | Antibodies, Viral | 2 | 2022 | 622 | 0.280 |
Why?
| | Embryo Implantation | 2 | 2017 | 30 | 0.260 |
Why?
| | HLA-DR alpha-Chains | 1 | 2023 | 4 | 0.210 |
Why?
| | Humans | 15 | 2025 | 136783 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 2 | 2025 | 2677 | 0.210 |
Why?
| | HLA-DRB1 Chains | 1 | 2023 | 112 | 0.200 |
Why?
| | Biological Therapy | 1 | 2022 | 29 | 0.190 |
Why?
| | Genetic Association Studies | 1 | 2023 | 376 | 0.180 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2024 | 654 | 0.180 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 556 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 752 | 0.170 |
Why?
| | Alleles | 1 | 2023 | 888 | 0.170 |
Why?
| | Stromal Cells | 2 | 2017 | 111 | 0.160 |
Why?
| | Propensity Score | 1 | 2020 | 288 | 0.150 |
Why?
| | Administration, Inhalation | 1 | 2020 | 683 | 0.150 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 451 | 0.150 |
Why?
| | Genetic Variation | 1 | 2023 | 985 | 0.150 |
Why?
| | Mice, SCID | 1 | 2018 | 367 | 0.140 |
Why?
| | Odds Ratio | 1 | 2020 | 1063 | 0.140 |
Why?
| | Early Detection of Cancer | 1 | 2022 | 419 | 0.140 |
Why?
| | Antigen Presentation | 1 | 2018 | 215 | 0.140 |
Why?
| | Receptors, OSM-LIF | 1 | 2016 | 1 | 0.130 |
Why?
| | Decidua | 1 | 2017 | 24 | 0.130 |
Why?
| | Cell Shape | 1 | 2017 | 57 | 0.130 |
Why?
| | Myometrium | 1 | 2017 | 39 | 0.130 |
Why?
| | Endometriosis | 1 | 2017 | 50 | 0.130 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2190 | 0.120 |
Why?
| | Female | 8 | 2025 | 72840 | 0.120 |
Why?
| | Logistic Models | 1 | 2020 | 2060 | 0.120 |
Why?
| | Viral Matrix Proteins | 1 | 2015 | 30 | 0.120 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2017 | 209 | 0.120 |
Why?
| | STAT3 Transcription Factor | 1 | 2016 | 205 | 0.120 |
Why?
| | Phenotype | 1 | 2023 | 3199 | 0.120 |
Why?
| | Smoking | 1 | 2022 | 1633 | 0.110 |
Why?
| | Herpesvirus 4, Human | 1 | 2015 | 167 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3399 | 0.100 |
Why?
| | Neovascularization, Pathologic | 1 | 2015 | 301 | 0.100 |
Why?
| | Vaccination | 1 | 2022 | 1378 | 0.100 |
Why?
| | Middle Aged | 4 | 2025 | 33200 | 0.100 |
Why?
| | Cell Movement | 1 | 2017 | 969 | 0.100 |
Why?
| | Cell Proliferation | 1 | 2018 | 2473 | 0.090 |
Why?
| | Adult | 4 | 2024 | 37616 | 0.090 |
Why?
| | Cohort Studies | 1 | 2020 | 5718 | 0.080 |
Why?
| | Aged | 2 | 2020 | 23729 | 0.080 |
Why?
| | Male | 6 | 2025 | 67361 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 1092 | 0.070 |
Why?
| | Mutation | 1 | 2018 | 3953 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 10331 | 0.060 |
Why?
| | Mice | 2 | 2018 | 17731 | 0.050 |
Why?
| | Signal Transduction | 1 | 2016 | 5065 | 0.050 |
Why?
| | Disease Progression | 2 | 2024 | 2750 | 0.050 |
Why?
| | Phosphorylation | 2 | 2017 | 1756 | 0.050 |
Why?
| | Fever | 1 | 2022 | 307 | 0.040 |
Why?
| | Neoplasms | 1 | 2015 | 2644 | 0.040 |
Why?
| | DNA Methylation | 1 | 2024 | 644 | 0.040 |
Why?
| | Animals | 2 | 2018 | 36768 | 0.040 |
Why?
| | MicroRNAs | 1 | 2024 | 697 | 0.030 |
Why?
| | Stress Fibers | 1 | 2017 | 19 | 0.030 |
Why?
| | Dinucleoside Phosphates | 1 | 2016 | 27 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2017 | 72 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3537 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 777 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2024 | 2831 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 170 | 0.030 |
Why?
| | Menstrual Cycle | 1 | 2017 | 132 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 464 | 0.030 |
Why?
| | Actins | 1 | 2017 | 415 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 945 | 0.030 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2015 | 187 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1117 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2015 | 484 | 0.020 |
Why?
| | Lung | 1 | 2025 | 4065 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2015 | 707 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2015 | 1150 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4194 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 2999 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6792 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4279 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 15564 | 0.010 |
Why?
| | Pregnancy | 1 | 2017 | 6731 | 0.010 |
Why?
|
|
Liao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|